MIER1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.240200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.554200E-01
Normal-vs-Stage2
4.785200E-01
Normal-vs-Stage3
4.557600E-02
Normal-vs-Stage4
4.095800E-01
Stage1-vs-Stage2
5.507400E-01
Stage1-vs-Stage3
3.023400E-01
Stage1-vs-Stage4
5.262300E-02
Stage2-vs-Stage3
1.404000E-01
Stage2-vs-Stage4
6.280400E-02
Stage3-vs-Stage4
1.441840E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.752000E-01
Normal-vs-AfricanAmerican
8.961600E-01
Normal-vs-Asian
3.285800E-01
Caucasian-vs-AfricanAmerican
1.384590E-01
Caucasian-vs-Asian
7.281600E-01
AfricanAmerican-vs-Asian
2.061800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.895600E-01
Normal-vs-Female
4.821400E-01
Male-vs-Female
4.797200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.049000E-01
Normal-vs-Age(41-60Yrs)
8.823800E-01
Normal-vs-Age(61-80Yrs)
3.071800E-01
Normal-vs-Age(81-100Yrs)
5.008300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.251200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.673600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.961000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.883240E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.382200E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.474200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.054850E-01
Normal-vs-Daily Drinker
2.664000E-01
Normal-vs-Weekly Drinker
2.004000E-01
Normal-vs-Occasional Drinker
7.882600E-01
Normal-vs-Social Drinker
6.013200E-01
Non Drinker-vs-Daily Drinker
9.904000E-01
Non Drinker-vs-Weekly Drinker
9.075400E-01
Non Drinker-vs-Occasional Drinker
3.054000E-02
Non Drinker-vs-Social Drinker
1.270210E-01
Daily Drinker-vs-Weekly Drinker
9.384200E-01
Daily Drinker-vs-Occasional Drinker
9.552400E-02
Daily Drinker-vs-Social Drinker
2.470600E-01
Weekly Drinker-vs-Occasional Drinker
9.588000E-02
Weekly Drinker-vs-Social Drinker
2.297200E-01
Occasional Drinker-vs-Social Drinker
6.570800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.272000E-01
Normal-vs-Grade 2
1.714390E-02
Normal-vs-Grade 3
3.663700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.443900E-03
Grade 1-vs-Grade 3
9.126300E-02
Grade 1-vs-Grade 4
2.272000E-01
Grade 2-vs-Grade 3
2.791000E-01
Grade 2-vs-Grade 4
1.714390E-02
Grade 3-vs-Grade 4
3.663700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.840400E-01
Normal-vs-NonDiabetic
3.216400E-01
Diabetic-vs-NonDiabetic
5.916800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.362800E-01
Normal-vs-NoPancreatitis
3.425400E-01
Pancreatitis-vs-NoPancreatitis
9.504600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.148400E-01
Normal-vs-N1
5.042200E-01
N0-vs-N1
2.353600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.434000E-01
Normal-vs-TP53-NonMutant
4.794200E-01
TP53-Mutant-vs-TP53-NonMutant
3.296600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
